Never Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by $5 Billion

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-bristol-myers-squibb.jpg" NAME"Never Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by $5 Billion" ALT"Never Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by…

Continue ReadingNever Say Never: Why Taking Out Bristol-Myers Squibb Could Boost Pfizer's Value by $5 Billion

Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-scientist5.jpg" NAME"Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos" ALT"Questions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos"March 28, 2017By <A HREF"http://www.biospace.com/news_subject_all_results.aspx?CatagoryId4...…

Continue ReadingQuestions Arise Over the World's Richest Doctor's 'Breakthrough' Cancer Therapy Promo Videos

Filings Reveal Concert Pharma Spurned $250 Million Buyout Offer From Vertex in November 2016

  • Post author:
  • Post category:BioPharma

<IMG SRC"http://enewsletters.biospace.com/images/news/biospace-news-815x450-deal2.jpg" NAME"Filings Reveal Concert Pharma Spurned $250 Million Buyout Offer From Vertex in November 2016" ALT"Filings Reveal Concert Pharma Spurned $250 Million Buyout Offer From Vertex in November 2016"March…

Continue ReadingFilings Reveal Concert Pharma Spurned $250 Million Buyout Offer From Vertex in November 2016